Everest Medicines enters exclusive license agreement with Micot to commercialize innovative dual-targeting peptide MT1013 for Secondary Hyperparathyroidism in China and Asia-Pacific, excluding Japan.

The EU institutions have finalized political agreement on the Pharma Package, introducing revisions to data and market protection while mandating supply across member states.

Bristol Myers Squibb announced robust Q4 and full-year 2025 financial results today, driven by 16% growth in its immuno-oncology portfolio and key regulatory milestones.

UCB has received a positive opinion from the CHMP for Kygevvi, marking a potential first-in-class treatment for the ultra-rare mitochondrial disease thymidine kinase 2 deficiency across Europe.

Pharmaceutical companies are accelerating M&A and TrumpRx deals amid dual pressures from patent expirations risking $230B in sales and new government pricing interventions.[1]

Tanabe Pharma Corporation revealed strategic organizational and personnel changes on February 2, 2026, aimed at enhancing efficiency in pharmaceutical R&D, manufacturing, and regulatory compliance across its Asian operations.

The European Medicines Agency has updated its training module EV-M8, focusing on considerations for the international transfer of personal health data in Individual Case Safety Reports (ICSRs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) originating in the EU.

Merck has begun construction on a $3 billion manufacturing facility in Virginia as part of its $70 billion U.S. investment to expand domestic production and mitigate tariff risks.

Suzhou-based Alphamab's KN-026 combined with chemotherapy reduced disease progression risk by 75% in HER2-positive gastric cancer patients, positioning it as a potential new standard of care.

Morgan Lewis has strengthened its global life sciences capabilities by recruiting Dr. Alexander Meier, former VP and head of legal regulatory strategy at Moderna, to its Munich office, enhancing regulatory advisory for pharmaceutical and biotech clients in Europe.